Cargando…

Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV

OBJECTIVES: Many randomized and cohort studies have reported a survival benefit with cotrimoxazole prophylaxis without detecting a difference in tuberculosis (TB) incidence by cotrimoxazole status. However, several in vitro studies have reported that cotrimoxazole possesses anti-TB activity. We soug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffmann, Christopher J., Chaisson, Richard E., Martinson, Neil A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885446/ https://www.ncbi.nlm.nih.gov/pubmed/24421903 http://dx.doi.org/10.1371/journal.pone.0083750

Ejemplares similares

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV
por: Ku, Stephane Wen‐Wei, et al.
Publicado: (2019)

Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa
por: Hoffmann, Christopher J, et al.
Publicado: (2014)

Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda
por: Orishaba, Philip, et al.
Publicado: (2020)

Cotrimoxazole Prophylaxis and Risk of Severe Anemia or Severe Neutropenia in HAART-Exposed, HIV-Uninfected Infants
por: Dryden-Peterson, Scott, et al.
Publicado: (2013)

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa
por: Moodley, Dhayendre, et al.
Publicado: (2013)

Tuberculosis and Hepatic Steatosis Are Prevalent Liver Pathology Findings among HIV-Infected Patients in South Africa
por: Hoffmann, Christopher J., et al.
Publicado: (2015)

High Prevalence of Pulmonary Tuberculosis but Low Sensitivity of Symptom Screening among HIV-Infected Pregnant Women in South Africa
por: Hoffmann, Christopher J., et al.
Publicado: (2013)

Facilitators and barriers to cotrimoxazole and nevirapine prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe
por: Sibanda, E, et al.
Publicado: (2012)

Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China
por: Cheng, Wei, et al.
Publicado: (2015)

Retrospective evaluation of cotrimoxazole use as preventive therapy in people living with HIV/AIDS in Boru Meda Hospital
por: Geresu, Berhanu, et al.
Publicado: (2014)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design
por: Anywaine, Zacchaeus, et al.
Publicado: (2015)

Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon
por: Janssen, Saskia, et al.
Publicado: (2015)

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa*
por: Kasirye, R, et al.
Publicado: (2015)

Cotrimoxazole Prophylaxis Associated With Reduced Anemia Hazard in HIV-Exposed Infants in a Malaria-Endemic Setting
por: Ewing, Alexander, et al.
Publicado: (2017)

Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance in Streptococcus mutans and Streptococcus sobrinus with Varied Polymorphisms in the Target Genes folA and folP
por: William, Buwembo, et al.
Publicado: (2012)

Manuscript title: Facilitators and barriers to cotrimoxazole prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe
por: Sibanda, Euphemia L., et al.
Publicado: (2015)

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial
por: Polyak, Christina S., et al.
Publicado: (2016)

Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV‐exposed infants in a randomized controlled trial, Botswana
por: Powis, Kathleen M, et al.
Publicado: (2017)

Trials of Tuberculosis-Preventive Therapy in People with HIV Infection
por: Swindells, Susan, et al.
Publicado: (2020)

Operational research in malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV
por: Harries, Anthony D, et al.
Publicado: (2011)

Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid—Preventive therapies for people living with HIV
por: Müller, Pia, et al.
Publicado: (2022)

Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
por: Vojnov, Lara, et al.
Publicado: (2022)

Brief Report: Cessation of Long-Term Cotrimoxazole Prophylaxis in HIV-Infected Children Does Not Alter the Carriage of Antimicrobial Resistance Genes
por: Francis, Freddy, et al.
Publicado: (2020)

Risk Factors for Developing Active Tuberculosis After the Treatment of Latent Tuberculosis in Adults Infected With Human Immunodeficiency Virus
por: Amoakwa, Kojo, et al.
Publicado: (2014)

Ten Years of Surveillance for Invasive Streptococcus pneumoniae during the Era of Antiretroviral Scale-Up and Cotrimoxazole Prophylaxis in Malawi
por: Everett, Dean B., et al.
Publicado: (2011)

Plasma Kynurenine-to-Tryptophan Ratio, a Highly Sensitive Blood-Based Diagnostic Tool for Tuberculosis in Pregnant Women Living With Human Immunodeficiency Virus (HIV)
por: Adu-Gyamfi, Clement, et al.
Publicado: (2021)

Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study
por: Jiang, Junjun, et al.
Publicado: (2019)

Does cotrimoxazole prophylaxis in HIV patients increase the drug resistance of pneumococci? A comparative cross-sectional study in southern Ethiopia
por: Seid, Mohammed, et al.
Publicado: (2020)

Proportions of CD4+, CD8+ and B cell subsets are not affected by exposure to HIV or to Cotrimoxazole prophylaxis in Malawian HIV-uninfected but exposed children
por: Longwe, Herbert, et al.
Publicado: (2015)

Readmission and death following hospitalization among people with HIV in South Africa
por: Hoffmann, Christopher J., et al.
Publicado: (2019)

High Incidence of Tuberculosis in the Absence of Isoniazid and Cotrimoxazole Preventive Therapy in Children Living with HIV in Northern Ethiopia: A Retrospective Follow-Up Study
por: Alemu, Yihun Mulugeta, et al.
Publicado: (2016)

Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort
por: Salazar-Austin, Nicole, et al.
Publicado: (2019)

The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progression
por: Lassaunière, Ria, et al.
Publicado: (2018)

Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients
por: Adu-Gyamfi, Clement G, et al.
Publicado: (2017)

Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d’Ivoire: a prospective cohort study
por: Mounkaila Harouna, Aïda, et al.
Publicado: (2015)

Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol
por: Coutsoudis, Anna, et al.
Publicado: (2016)

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
por: Hutchinson, Eleanor, et al.
Publicado: (2011)

Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Infected Women Receiving Cotrimoxazole Prophylaxis: A Multicenter Randomized Placebo-Controlled Trial
por: González, Raquel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fvs653f64red3bult3b1cmpr4c